Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes? | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes?

Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes?

Journal Title: 
Lancet
Primary Author: 
Carraway HE
Author(s): 
Carraway HE
Original Publication Date: 
Saturday, July 29, 2023
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/37321236/
Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.